• SENSEX 81,592.45
    -318.56 (--0.39%)
  • BANKNIFTY 61,034.10
    -484.40 (--0.79%)
  • NSE
    2,007.60 2,007.60(%)
  • Hitachi Energy
    32,245.70 38,800.00(%)
  • SBI
    1,074.60 933.85(%)
  • TD Power Systems
    685.00 856.00(%)
  • Reliance Industries
    1,351.00 1,611.20(%)
  • Amber Enterp.
    6,909.00 8,970.00(%)
  • Bharti Airtel
    2,123.80 2,174.70(%)
  • Larsen & Toubro
    4,128.70 3,288.65(%)
  • Kalyan Jewellers
    684.95 327.15(%)
  • SBI Funds Mgt.
    512.45 433.55(%)
  • Cupid
    363.25 53.66(%)
  • Apollo Micro Sys
    477.55 477.55(%)
  • M & M
    3,330.00 2,743.15(%)
  • 3M India
    28,259.25 26,400.05(%)
  • Kotak Mah. Bank
    484.00 345.40(%)
  • Bajaj Finance
    1,118.60 1,177.60(%)
  • Cholaman.Inv.&Fn
    1,810.15 1,299.80(%)
  • Netweb Technol.
    4,272.00 5,810.00(%)
  • BLS Polymers
    279.80 288.00(%)
  • Maruti Suzuki
    12,800.00 10,984.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Goldline Pharmaceutical Ltd Trading

  • Indian Private
  • BSE Code : 95956.0
  • ISIN : INE1CLW01015
29.27 -2 (-5.31%)
  • As on 14 Nov 2026 (EOD)

  • Today’s Low

    29.27

  • Today’s High

    30.74

  • Open

    30.38

  • Perv Close

    30.91

  • 52W Low

    28.13

  • 52W High

    60.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    28.10

  • Div & Yield %

    0.00

  • Book Value(₹)

    25.05

  • Debt-Equity Ratio

    -5.31

  • AGM Date

    13-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    28.10

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.60

  • BV (₹)

    25.10

  • Sales( ₹ in Cr.)

    31.20

  • NP (in Cr.)

    4.12

  • NP Var(%)

    42.0

  • Div%

    0.0

  • CPS (₹)

    4.50

  • EPS (₹)

    4.30

  • Traded Value (₹ in Lakhs)

    28.10

  • 52 Week High

    60.00

  • 52 Week Low

    28.13

  • Price BSE

    29.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    28.10

  • P/C Ratio

    6.40

  • P/E Ratio

    6.80

  • Price Vs.BV

    4.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 31.20 28.06 23.57 19.85 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 31.20 28.06 23.57 19.85 - -
Other Income 0.00 0.00 0.00 0.00 - -
Stock Adjustments -0.57 -0.71 2.12 -0.09 - -
Total Income 30.63 27.35 25.69 19.76 - -
EXPENDITURE :            
Raw Materials 10.63 10.09 8.19 5.74 - -
Power and Fuel Cost 0.02 0.02 0.02 0.02 - -
Employee Cost 5.71 4.71 4.69 4.63 - -
Other Manufacturing Expenses 0.05 0.04 0.01 0.02 - -
Selling and Administration Expenses 7.16 6.33 8.42 6.93 - -
Miscellaneous Expenses 0.00 0.09 0.04 0.20 - -
Employee Benefit Expenses 5.71 4.71 4.69 4.63 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 23.56 21.29 21.38 17.55 - -
Operating Profit 7.09 6.06 4.30 2.21 - -
Interest 1.46 1.95 1.61 1.63 - -
Gross Profit 5.63 4.11 2.69 0.58 - -
Depreciation 0.24 0.25 0.16 0.18 - -
Profit Before Tax 5.39 3.86 2.53 0.40 - -
Current Tax 1.43 0.99 0.67 0.14 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.17 0.03 0.05 0.01 - -
Reported Net Profit 4.12 2.83 1.81 0.26 - -
Extraordinary Items 0.00 -0.07 -0.03 -0.13 - -
Adjusted Net Profit 4.12 2.90 1.84 0.39 - -
Adjustment below Net Profit 0.09 -3.47 -0.28 -0.65 - -
P & L Balance brought forward 1.55 2.40 2.08 2.48 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.22 0.22 -0.15 0.00 - -
P & L Balance carried down 5.54 1.55 3.76 2.08 - -
Dividend 0.22 0.22 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 5.97 4.11 7.85 1.28 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 18.03 12.25 26.34 20.42 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    59.54%

  • Public Share Holding

    40.46%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,715,982 59.54 5,715,982 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,715,982 59.54 5,715,982 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30,000 0.31 30,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 9,000 0.09 9,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 39,000 0.41 39,000 2
2] Non Institution
Bodies Corporate 235,000 2.45 235,000 6
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 54,000 0.56 54,000 9
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 120,000 1.25 120,000 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,658,003 17.27 1,658,003 20
Individuals holding nominal share capital up to Rs. 1 lakh 1,637,015 17.05 1,637,015 355
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 141,000 1.47 141,000 20
Sub Total 3,845,018 40.05 3,845,018 411
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,600,000 100.00 9,600,000 417

Company Background

Goldline Pharmaceutical LtdTrading

  • Goldline Pharmaceutical Ltd
  • BSE Code : 95956.0
  • ISIN : INE1CLW01015

  • Incorporation Year

    2004

  • Registered Office

    103 F-1 Leela Apartment Shilpa
    HSG Society Shanidham Narendra, Nagpur,
    Maharashtra-440015

  • Telephone

    +91 712 278 6666

  • FAX

  • Chairman

    AMOL LAXMIKANT MUJUMDAR

  • Managing Director

    AMOL LAXMIKANT MUJUMDAR

  • Company Secretary

    Ruchi Sanket Modi

  • Auditor

    B Shroff & Co.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Goldline Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Goldline Pharmaceutical 29.27 31.20 31.20 0.00 29.32
Abbott India 26,413.45 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,039.00 2,304.07 2,275.58 84.95 27.86
Glaxosmi. Pharma 2,669.55 3,932.76 3,790.20 39.67 58.17
Evonile Pharma 1,520.30 393.10 354.33 -1,333.60 15.94
Cipla 1,393.00 20,102.60 18,979.95 42.46 13.88
Bliss GVS Pharma 673.00 773.53 729.81 43.87 12.51
Amrutanjan Healt 509.00 520.13 502.55 25.68 24.16
Fermenta Biotec. 473.80 474.15 450.25 22.39 18.77
Guj. Themis Bio. 389.25 168.25 165.82 104.08 18.05
Ambalal Sarabhai 38.59 19.52 3.94 65.41 6.77